Team

Mr. Evans is CEO of Texas Neurology, among the largest and most comprehensive neurology practices in the country. He is extremely active in the American Academy of Neurology, where he currently serves as Chair of the Committee on Public Engagement and Chair of Health Policy Subcommittee, Member of Advocacy, and Member of Industry Roundtable.  Mr. Evans won the AAN President’s Award in 2022 for his outstanding service to the AAN and the profession of neurology.  He has an extensive background in practice management consulting with an emphasis on the implementation of ancillary services within physician practices. He’s also worked with Biogen in preparation for their launch of Tysabri. These turnkey consultancies involved establishing in-office infusion centers, which were instrumental to the launch and delivery of this biological to many of the country’s most prominent MS centers.

As CEO of Dent Neurologic Institute, Dr. Fritz helped Dent grow to become among the largest outpatient neurology centers in the US. He has over 25 years of experience in medical management and research in both medical practice and industry settings. He regularly publishes and presents on the business of neurology and in areas of neuroscience research. He is an active member of the American Academy of Neurology (AAN), participating in a wide range of committees including vice-chair of the Axon Registry Committee, past Chair of the AAN’s Business Section, co-chair of the APP Workgroup, and member of Practice, Medical Economics and Management, Payment Policy, Health Services Research Group, Imaging, and Practice Management and Technology Committees.

Ms. Mann is the Chief Operating Officer at Dent Neurologic Institute. She has opened, operated and consulted on numerous infusion centers around the U.S. She is the recipient of the Business First award for the ground-up development of infusion centers and most recently the Intalere Healthcare Achievement Award for the DENT Infusion Center. She is a nationally recognized speaker about introducing new therapies for infusion, sophisticated inventory management, and development and management of infusion centers including revenue cycle management. She lectures on the business and billing for complex infusion therapies at the American Academy of Neurology annual meetings.

Ms. Matecki currently serves dual roles as the Director of Business Development for NeuroNet GPO and also as the Manager of Purchasing and Contracting at DENT Neurologic Institute. She has been instrumental in developing processes and programs to organize and streamline the complexity of supply chain management in a healthcare setting. Ashley has worked closely with our vendors and manufacturers to develop relationships to help manage pricing, contracts, and rebates. Her experience and expertise in customer relations have proved to be a valuable asset to our NeuroNet team. She began her career at DENT in 2014 after completing her bachelor’s degree at Buffalo State College and a program of study in Chile and Peru. Ms. Matecki then pursued her Master’s degree in Business Administration, which she completed in 2019.